Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes

Core Viewpoint - The planned separation is part of Johnson & Johnson's strategy to streamline operations and concentrate on faster-growing business segments [1] Group 1 - Johnson & Johnson is executing a separation to enhance focus on its core, high-growth areas [1]